Skip to main content

Together we are beating cancer

Donate now

Cancer News

The latest news, analysis and opinion from Cancer Research UK

Phil Prime

Showing 12 out of 84 results

The theme for this year’s Peer Review Week is ‘research integrity’ – that really strikes a chord with our new columnists… The theme for this year’s Peer Review Week is ‘research integrity’ – that really strikes a chord with our new columnists…

by Phil Prime | Analysis | 21 September 2022

21 September 2022

This entry is part 8 of 14 in the series Research Integrity

This episode features Professor Richard Gilbertson. Richard is a paediatric oncology clinician scientist and is the Director of the Cancer Research UK Cambridge Centre. He talks about the challenges and successes of the childhood cancer research community, how he sees the future of the field and some of the incredible breakthroughs his lab has made on childhood brain cancers. This episode features Professor Richard Gilbertson. Richard is a paediatric oncology clinician scientist and is the Director of the Cancer Research UK Cambridge Centre. He talks about the challenges and successes of the childhood cancer research community, how he sees the future of the field and some of the incredible breakthroughs his lab has made on childhood brain cancers.

by Phil Prime | Podcast | 6 September 2022

6 September 2022

This entry is part 6 of 9 in the series Cancer Research Matters - series 1

This episode features outgoing CRUK Chief Scientist, Professor Karen Vousden. Known for her work on the tumour suppressor protein, p53, she has also worked on HPV and cancer metabolism. She talks about the success and challenges of work around p53, her joy at being involved in the early work around HPV, the frustrations of coming so close to a huge breakthrough and how life as a researcher has changed. This episode features outgoing CRUK Chief Scientist, Professor Karen Vousden. Known for her work on the tumour suppressor protein, p53, she has also worked on HPV and cancer metabolism. She talks about the success and challenges of work around p53, her joy at being involved in the early work around HPV, the frustrations of coming so close to a huge breakthrough and how life as a researcher has changed.

by Phil Prime | Podcast | 25 August 2022

25 August 2022

This entry is part 5 of 9 in the series Cancer Research Matters - series 1

We catch up with Dr Alexis Webb and find out about the upcoming Early Detection of Cancer Conference, the importance of collaboration and why these are exciting times for the field... We catch up with Dr Alexis Webb and find out about the upcoming Early Detection of Cancer Conference, the importance of collaboration and why these are exciting times for the field...

by Phil Prime | Interview | 18 August 2022

18 August 2022

Our policy department give us an update on the current state of play on post-Brexit science funding, what you can do to help and what we know about the Government’s ‘Plan B’… Our policy department give us an update on the current state of play on post-Brexit science funding, what you can do to help and what we know about the Government’s ‘Plan B’…

by Phil Prime | Analysis | 25 July 2022

25 July 2022

This entry is part 3 of 9 in the series Diversity in research

This episode features CRUK Chairman, Professor Sir Leszek Borysiewicz. Following a distinguished academic and clinical research career, Leszek’s roles have included Chief Executive of the Medical Research Council and Vice Chancellor of the University of Cambridge. He talks about the development of the HPV vaccine, the difficulties of navigating a research career and why we must start to embrace failure… even a negative result, he says, is positive. This episode features CRUK Chairman, Professor Sir Leszek Borysiewicz. Following a distinguished academic and clinical research career, Leszek’s roles have included Chief Executive of the Medical Research Council and Vice Chancellor of the University of Cambridge. He talks about the development of the HPV vaccine, the difficulties of navigating a research career and why we must start to embrace failure… even a negative result, he says, is positive.

by Phil Prime | Podcast | 20 July 2022

20 July 2022

This entry is part 4 of 9 in the series Cancer Research Matters - series 1

We recently welcomed some early career researchers to observe some of the panel discussions and interviews for our Research Careers Committee. So, how did they get on? We recently welcomed some early career researchers to observe some of the panel discussions and interviews for our Research Careers Committee. So, how did they get on?

by Phil Prime | In depth | 6 July 2022

6 July 2022

Nobody fully understands why people go off food in response to infection, early pregnancy and some chemotherapies for cancer. A flurry of research published in recent years has narrowed down the search for the culprit mechanism, and Cancer Research UK-funded researchers have just found another piece of the puzzle. Nobody fully understands why people go off food in response to infection, early pregnancy and some chemotherapies for cancer. A flurry of research published in recent years has narrowed down the search for the culprit mechanism, and Cancer Research UK-funded researchers have just found another piece of the puzzle.

by Phil Prime | In depth | 15 June 2022

15 June 2022

This episode features Professor Sara Zanivan. She talks about how understanding the tumour microenvironment has developed over the past 20 years, how the techniques of proteomics have really freed researchers to ask the important questions and why we could even see mass-spec proteomics in the clinic. This episode features Professor Sara Zanivan. She talks about how understanding the tumour microenvironment has developed over the past 20 years, how the techniques of proteomics have really freed researchers to ask the important questions and why we could even see mass-spec proteomics in the clinic.

by Phil Prime | Podcast | 23 May 2022

23 May 2022

This entry is part 3 of 9 in the series Cancer Research Matters - series 1

Find out what a Registered Report is, how you can get involved, and why this relatively small change in the way research is done could have a real impact on reproducibility issues and even patient outcomes. Find out what a Registered Report is, how you can get involved, and why this relatively small change in the way research is done could have a real impact on reproducibility issues and even patient outcomes.

by Phil Prime | Interview | 16 May 2022

16 May 2022